Compare · CELC vs ELV
CELC vs ELV
Side-by-side comparison of Celcuity Inc. (CELC) and Elevance Health Inc. (ELV): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELC and ELV operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $85.74B, about 19.6x CELC ($4.39B).
- Over the past year, CELC is up 685.7% and ELV is up 6.1% - CELC leads by 679.6 points.
- CELC has been more active in the news (19 items in the past 4 weeks vs 8 for ELV).
- ELV has more recent analyst coverage (23 ratings vs 14 for CELC).
- Company
- Celcuity Inc.
- Elevance Health Inc.
- Price
- $90.12+0.37%
- $395.05+0.05%
- Market cap
- $4.39B
- $85.74B
- 1M return
- -36.76%
- +1.40%
- 1Y return
- +685.70%
- +6.09%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2017
- News (4w)
- 19
- 8
- Recent ratings
- 14
- 23
Celcuity Inc.
Celcuity Inc., a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest CELC
- SEC Form 4 filed by Director Murphy Polly A.
- SEC Form 4 filed by Director Buller Richard E
- Director Murphy Polly A. was granted 1,530 shares, increasing direct ownership by 31% to 6,530 units (SEC Form 4)
- Director Dalvey David was granted 1,530 shares (SEC Form 4)
- Director Romp Charles R was granted 1,530 shares, increasing direct ownership by 712% to 1,745 units (SEC Form 4)
- Director Furcht Leo was granted 1,530 shares, increasing direct ownership by 14% to 12,530 units (SEC Form 4)
- Director Nigon Richard was granted 1,530 shares, increasing direct ownership by 2% to 80,565 units (SEC Form 4)
- Director Buller Richard E was granted 1,530 shares (SEC Form 4)
- Celcuity Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits
- SEC Form 424B5 filed by Celcuity Inc.
Latest ELV
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
- SEC Form 11-K filed by Elevance Health Inc.
- SEC Form 11-K filed by Elevance Health Inc.
- Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide
- CAO & Controller Penczek Ronald W sold $148,766 worth of shares (369 units at $403.16), decreasing direct ownership by 9% to 3,740 units (SEC Form 4)
- Elevance Health Makes Chronic Care Easier to Navigate With Connected, Personalized Support
- Director Dixon Robert L Jr sold $60,667 worth of shares (151 units at $401.77), decreasing direct ownership by 1% to 10,734 units (SEC Form 4)
- Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
- CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)